Cancer Network spoke with Kathryn Cecilia Arbour, MD, of Memorial Sloan-Kettering Cancer Center, about the most recent research on checkpoint inhibitors in oncology.
Kathryn Cecilia Arbour, MD
Advertisement
Articles by Kathryn Cecilia Arbour, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Delays Decision on Subcutaneous Isatuximab in Multiple Myeloma
2
TERN-701 Earns FDA Breakthrough Therapy Designation in Ph+ CML
3
In Vivo CAR Engineering and the Next Phase of Cellular Immunotherapy
4
ASCO Releases New Patient-Clinician Communication Guidelines
5